SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

Share Price is delayed by 15 minutes
Get Live Data
17.00    0.00 (0.00%)
Bid:
16.00
Ask:
18.00
Spread: 2.00 (12.50%)
Market Cap: £12.86m
FIPP Live PriceLast checked at - London Stock Exchange

Intraday Frontier Ip Share Chart

Director/PDMR Dealing

11 Nov 2022 15:07

RNS Number : 1974G
Frontier IP Group plc
11 November 2022
 

RNS

AIM: FIPP

11 November 2022

 

 

 

Frontier IP Group plc

 

("Frontier IP" or the "Group")

 

Director/PDMR Dealing

 

Frontier IP, a specialist in commercialising intellectual property, announces that Andrew Richmond, Non-Executive Chairman, has, between 9 November 2022 and 11 November 2022, sold a total of 150,000 ordinary shares of 10p each ("Ordinary Shares") in Frontier IP, at an average price of 69.0 pence per share.

 

Following the sale, Andrew Richmond has an interest in 850,000 Ordinary Shares, representing 1.55% of the Group's issued share capital.

 

The notification below, which has been made in accordance with the requirements of the UK Market Abuse Regulation, provides further detail.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Andrew Richmond

 

2

Reason for the notification

a)

Position/status

Non-Executive Chairman

 

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Frontier IP Group plc

 

b)

LEI

213800BRYUKQPJWKJ312

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 10p

 

ISIN: GB00B63PS212

 

b)

Nature of the transaction

Sale of Ordinary Shares

 

 

c)

Price(s) and volume(s)

 

 

 

 

 

 

 

 

 

 Price(s)

Volume(s)

71.25 pence

30,000 shares sold (9 November 2022)

68.5 pence

50,000 shares sold (10 November 2022)

68.2 pence

25,000 shares sold (10 November 2022)

68.5 pence

45,000 shares sold (11 November 2022)

d)

Aggregated information

 

- Aggregated volume

 

- Price

 

- Aggregate amount

 

 

 

150,000

 

Average price of 69 pence per share

 

£103,500

e)

Date of the transactions

9 November 2022, 10 November 2022 and 11 November 2022

 

f)

Place of the transaction

London Stock Exchange (AIM)

 

 

 

ENQUIRIES

 

Frontier IP Group Plc

Neil Crabb, Chief Executive

 

Andrew Johnson, Communications & Investor Relations

Company website: www.frontierip.co.uk

 

T: 020 3968 7815 neil@frontierip.co.uk

 

M: 07464 546 025

andrew.johnson@frontierip.co.uk

 

Allenby Capital Limited (Nominated Adviser)

Nick Athanas / George Payne

 

T: 0203 328 5656

Singer Capital Markets (Broker)

Sandy Fraser / Harry Gooden / George Tzimas

T: 0207 496 3000

 

 

ABOUT FRONTIER IP

Frontier IP unites science and commerce by identifying strong intellectual property and accelerating its development through a range of commercialisation services. A critical part of the Group's work is involving relevant industry partners at an early stage of development to ensure technology meets real world demands and needs.

 

The Group looks to build and grow a portfolio of equity stakes and licence income by taking an active involvement in spin-out companies, including support for fund raising and collaboration with relevant industry partners at an early stage of development.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGPGAUGUPPGAG
Date   Source Headline
2nd May 201312:00 pmRNSChange of Adviser
24th Apr 20137:00 amRNSRe Portfolio Company
23rd Apr 20137:00 amRNSRe Portfolio Company
28th Mar 20137:01 amRNSHalf Year Results
19th Mar 20138:37 amRNSHolding(s) in Company
14th Mar 20133:16 pmRNSHolding(s) in Company
16th Jan 20137:00 amRNSGrant of Options
31st Dec 201211:45 amRNSResult of AGM
11th Dec 20127:00 amRNSPortfolio Company - Tate & Lyle Contract
4th Dec 20124:23 pmRNSHolding(s) in Company
30th Nov 201212:43 pmRNSResult of General Meeting
6th Nov 20123:43 pmRNSCirc re. Conditional Placing
29th Oct 20127:00 amRNSPreliminary Results
26th Oct 20124:22 pmRNSAppointment of NOMAD & Broker
28th Sep 20127:00 amRNSHalf Year Results
28th Sep 20127:00 amRNSTrading Update
12th Jun 20127:00 amRNSProspective Fund Management Agreement
8th Jun 20127:00 amRNSNew Spin-out Company
23rd Mar 20127:00 amRNSHalf Year Results
8th Mar 201210:44 amRNSHolding in Company
24th Feb 20127:00 amRNSAppointment of NOMAD & Broker
1st Feb 20127:00 amRNSChange of Name of Nomad & Broker
16th Dec 20117:00 amRNSBoard Appointment
30th Sep 20114:46 pmRNSRe: Annual Report and Accounts
23rd Sep 20117:00 amRNSPreliminary Results
22nd Jul 20117:00 amRNSTrading Update
26th May 20117:00 amRNSNew University Agreement
3rd Mar 20117:00 amRNSHalf Year Results
31st Jan 20118:01 amRNSAdmission to AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.